Pronóstico funcional a 3 meses de pacientes hospitalizados por ictus isquémico agudo en Aragón: análisis regional de la repercusión de la COVID-19

Tejada Meza, H. (Universidad de Zaragoza) ; Lambea Gil, Á. (Universidad de Zaragoza) ; Villar Yus, C. ; Pérez Lázaro, C. (Universidad de Zaragoza) ; Navarro Pérez, M.P. (Universidad de Zaragoza) ; Campello Morer, I. ; Giménez Muñoz, Á. ; Artal Roy, J. ; Alberti González, O. ; Hernando Quintana, N. ; Ruiz Palomino, P. ; Crespo Burillo, J.A. ; García Arguedas, C. ; Ballester Marco, L. ; Palacin Larroy, M. ; Seral Moral, M. ; Marta Moreno, J. ; en, nombre, del, Grupo, de, Estudio, de, Enfermedades, Neurovasculares-Sociedad, Aragonesa, de, Neurologia, (GEENV-SARAN)

Resumen: Introduction: The COVID-19 pandemic has had an impact on ischaemic stroke management, with a reported decrease in hospital admissions, and even disruptions in healthcare and increased in-hospital mortality. However, there is a lack of evidence on the impact of the pandemic on functional prognosis. The aim of this study is to analyse the effect of the COVID-19 pandemic on the 3-month functional outcomes of patients hospitalised due to acute ischaemic stroke in Aragon (Spain). Materil and methods: We reviewed the data of all patients admitted due to ischaemic stroke to any hospital in our regional healthcare system between 30 December 2019 and 3 May 2020. We compared modified Rankin Scale scores and mortality at 3 months in patients hospitalised before and after the declaration of a state of emergency due to the COVID-19 pandemic. Results: In total, 318 patients with acute ischaemic stroke met our inclusion criteria. No differences were observed between periods in global or specific characteristics, with the exception of a higher proportion of patients older than 80 years during the first period (42.2% vs. 29.0%, P=.028). In the comparative analysis, we found no significant differences in mortality (12.3 vs. 7.9, P=.465) or in the proportion of patients with modified Rankin Scale scores = 2 (57.7% vs. 57.1%, P=.425) at 3 months. Conclusion: To our knowledge, this is the first study to analyse the impact of COVID-19 pandemic on the 3-month functional outcomes of patients with ischaemic stroke. In our region, there has been no increase in rates of mortality or disability at 3 months in patients admitted due to ischaemic stroke during the pandemic.

Idioma: Español

DOI: 10.1016/j.nrl.2021.02.008

Año: 2021

Publicado en: Neurología (Barcelona) 36, 7 (2021), 531-536
ISSN: 0213-4853

Factor impacto JCR: 5.486 (2021)

Categ. JCR: CLINICAL NEUROLOGY rank: 46 / 212 = 0.217 (2021) - Q1 - T1

Factor impacto CITESCORE: 4.7 - Medicine (Q2)

Factor impacto SCIMAGO: 0.55 - Neurology (clinical) (Q2) - Medicine (miscellaneous) (Q2)

Tipo y forma: Artículo (Versión definitiva)

Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)